Showing results (711-720 of 835) with videos related to
Sort By:
Pageof 84
Biorxiv : the Preprint Server for Biology|May 20, 2024
Channel width modulates the permeability of DNA origami based nuclear pore mimicsQingzhou Feng, Martin Saladin, Chunxiang Wu, et al.Pathogens (Basel, Switzerland)|November 27, 2024
Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 EmergenceAlice M Joyce, Jack D Hill, Theocharis Tsoleridis, et al.Food Science & Nutrition|July 17, 2023
Wnt/β-catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET studyChukwuebuka Egbuna, Kingsley C Patrick-Iwuanyanwu, Eugene N Onyeike, et al.Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.Proceedings of the National Academy of Sciences of the United States of America|February 17, 2026
Ion transport through reconfigurable nanoparticle-surfactant stabilized droplet interface bilayersXuefei Wu, Han Xue, Zachary Fink, et al.Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.Scientific Reports|November 12, 2021
Fine-scale spatial segregation in a pelagic seabird driven by differential use of tidewater glacier frontsPhilip Bertrand, Joël Bêty, Nigel G Yoccoz, et al.Journal of Innate Immunity|May 24, 2014
Recombinant human L-ficolin directly neutralizes hepatitis C virus entryMohamed R Hamed, Richard J P Brown, Carsten Zothner, et al.Pageof 84